TY - JOUR
T1 - Spontaneous resolution of transfusion‐associated graft‐versus‐host disease
AU - Mori, S.
AU - Ozaki, K.
AU - Ishida, A.
AU - Tokuhira, M.
AU - Nakajima, H.
AU - Kizaki, M.
AU - Sugiura, H.
AU - Kikuchi, A.
AU - Handa, M.
AU - Kawai, Y.
AU - Yamamori, S.
AU - Ikeda, Y.
PY - 1995/5
Y1 - 1995/5
N2 - BACKGROUND: Transfusion‐associated graft‐versus‐host disease (TA‐GVHD) is a serious complication of blood transfusion that is characterized by high fever, a scaly maculopapular erythematous rash, diarrhea, hepatocellular damage with marked elevation of liver function test values, and pancytopenia. It can occur in immunocompetent as well as immunocompromised recipients. The existence of atypical TA‐GVHD that resolves spontaneously and does not exhibit all of the manifestations has been suggested, but there has been to date no documented diagnosis of GVHD supported by evidence of engraftment. CASE REPORT: A female patient presented and was diagnosed with acute myelogenous leukemia (AML:M4), and, after unsuccessful combination chemotherapy, she received a transfusion and developed manifestation of TA‐GVHD as well as evidence of chimerism. TA‐GVHD was proved by demonstrating Y chromosome‐specific genes in the skin by polymerase chain reaction. The manifestations of clinical GVHD abated within 4 months. CONCLUSION: Polymerase chain reaction analysis of Y chromosomes in specimens from female patients is useful in the diagnosis of suspected cases of spontaneously resolving TA‐GVHD. 1995 AABB
AB - BACKGROUND: Transfusion‐associated graft‐versus‐host disease (TA‐GVHD) is a serious complication of blood transfusion that is characterized by high fever, a scaly maculopapular erythematous rash, diarrhea, hepatocellular damage with marked elevation of liver function test values, and pancytopenia. It can occur in immunocompetent as well as immunocompromised recipients. The existence of atypical TA‐GVHD that resolves spontaneously and does not exhibit all of the manifestations has been suggested, but there has been to date no documented diagnosis of GVHD supported by evidence of engraftment. CASE REPORT: A female patient presented and was diagnosed with acute myelogenous leukemia (AML:M4), and, after unsuccessful combination chemotherapy, she received a transfusion and developed manifestation of TA‐GVHD as well as evidence of chimerism. TA‐GVHD was proved by demonstrating Y chromosome‐specific genes in the skin by polymerase chain reaction. The manifestations of clinical GVHD abated within 4 months. CONCLUSION: Polymerase chain reaction analysis of Y chromosomes in specimens from female patients is useful in the diagnosis of suspected cases of spontaneously resolving TA‐GVHD. 1995 AABB
UR - http://www.scopus.com/inward/record.url?scp=0029027145&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029027145&partnerID=8YFLogxK
U2 - 10.1046/j.1537-2995.1995.35595259155.x
DO - 10.1046/j.1537-2995.1995.35595259155.x
M3 - Article
C2 - 7740616
AN - SCOPUS:0029027145
SN - 0041-1132
VL - 35
SP - 431
EP - 435
JO - Transfusion
JF - Transfusion
IS - 5
ER -